Editorial: Targeting nucleotide metabolism for enhancing antitumor immunity
- PMID: 38715612
- PMCID: PMC11074342
- DOI: 10.3389/fimmu.2024.1412057
Editorial: Targeting nucleotide metabolism for enhancing antitumor immunity
Keywords: cancer; neoplasms; nucleotide; nucleotide metabolism; oncoimmunity.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Targeting nucleotide metabolism for enhancing antitumor immunity
References
-
- Sun M, Liu X, Xia L, Chen Y, Kuang L, Gu X, et al. . A nine-lncRNA signature predicts distant relapse-free survival of HER2-negative breast cancer patients receiving taxane and anthracycline-based neoadjuvant chemotherapy. Biochem Pharmacol. (2021) 189:114285. doi: 10.1016/j.bcp.2020.114285 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
